Chromatin Remodelling and Immunity: Volume 106
13%
off

Chromatin Remodelling and Immunity: Volume 106

Series edited by 

Free delivery worldwide

Available. Dispatched from the UK in 2 business days
When will my order arrive?

Description

Chromatin Remodelling and Immunity, Volume 106, the latest release in the Advances in Protein Chemistry and Structural Biology series is an essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins, with each thematically organized volume guest edited by leading experts in a broad range of protein-related topics.
show more

Product details

  • Hardback | 318 pages
  • 152 x 229 x 19.05mm | 660g
  • Academic Press Inc
  • San Diego, United States
  • English
  • 0128123923
  • 9780128123928

Table of contents

Chromatin Remodeling in Monocyte and Macrophage Activation
J.L. Schultze
Roles of SMC Complexes During T Lymphocyte Development and Function
J.S. Rawlings
The Role of Epigenetic Regulation in Transcriptional Memory in the Immune System
A.M. Woodworth and A.F. Holloway
Histone Acetylation and the Regulation of Major Histocompatibility Class II Gene Expression
K. Suzuki and Y. Luo
Mechanisms of Chromatin Remodeling and Repurposing During Extracellular Translocation
D.S. Pisetsky
Epigenetic Changes in Chronic Inflammatory Diseases
O. Fogel, C. Richard-Miceli and J. Tost
Regulation of Cellular Immune Responses in Sepsis by Histone Modifications
W.F. Carson IV and S.L. Kunkel
A New Molecular Mechanism Underlying the Anti-Tumor Effect of DNA Methylation Inhibitors Via an Anti-Viral Immune Response
Y. Saito, T. Nakaoka and H. Saito
Chromatin Remodeling and Plant Immunity
W. Chen, Q. Zhu, Y. Liu and Q. Zhang
show more

About Rossen Donev

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2010 Dr. Donev was appointed Senior Lecturer in Swansea University. Currently he is Head of Research at MicroPharm Ltd, UK and Director of Biomed Consult, UK. He has published more than 60 research papers, has chaired scientific meetings in Molecular Medicine and given plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on design of antibody-based oral treatment of pathological conditions of the colon and small intestines.
show more